Sub-hallucinogenic Doses of Psychedelics May Offer New Treatments for Depression, Related Disorders

Mind shifting psychedelics

Event Date

Zoom Webinar

David Olson, an assistant professor in the UC Davis departments of Chemistry and Biochemistry and Molecular Medicine, is investigating whether sub-hallucinogenic doses of psychedelic compounds like LSD and dimethyltryptamine could lead to new treatments for depression, anxiety and related disorders without the unwanted hallucinogenic effects.

Read more here:

Register here

Join the Zoom Webinar at the specified date and time: